(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. In vivo confirmation that Barx1 enables attenuation of Wnt signaling in
prospective stomach epithelium. (A,B) lacZ staining
in Barx1-/-;TOPGALTg (B) and control
Barx1+/-;TOPGALTg (A) mouse fetal stomach at
E16.5, when endogenous Wnt signaling is virtually abolished and there is no
esophageal activity (dashed lines) in control embryos but strong signals
remain in Barx1 mutants. (C,D) Histochemical
confirmation of persistent ß-gal activity in rostral
Barx1-/-;TOPGALTg stomach endoderm (D,
arrowheads) in relation to negligible signal in corresponding
Barx1+/-;TOPGALTg tissue (C).
(E,F) Further confirmation by lacZ in situ
hybridization of mRNA persistence in rostral E16.5
Barx1-/-;TOPGAL stomach endoderm (F), which contrasts with
the absence of expression in control E16.5 Barx1+/+;TOPGAL
tissue (E). (G-I) Persistent Wnt signaling is further revealed by
nuclear localization of ß-catenin in the emerging squamous epithelium of
Barx1-/- (G, boxed area shown at higher magnification in
H) but not control (I) foregut. (J,K) Similarly, ß-gal
activity persists in E18.5 Barx1-/-;Axin2lacZ
fetal stomach (K) compared with
Barx1+/-;Axin2lacZ controls (J). Dashed and
solid lines in A and J demarcate normal esophagus (Es) and duodenum (Du),
respectively. St, stomach; fore, forestomach; hind, hind-stomach (the blurred
boundaries between fore- and hindstomach are represented by dotted lines).
Scale bars: 75 µm in C; 60 µm in D; 75 µm in E,F.